Smartstop Self Storage REIT (NYSE:SMA) Updates FY 2026 Earnings Guidance

Smartstop Self Storage REIT (NYSE:SMA) issued an update on its FY 2026 earnings guidance on Wednesday. The company provided EPS guidance of 1.980-2.040 for the period, compared to the consensus earnings per share estimate of 2.010. The company issued revenue guidance of -.

Smartstop Self Storage REIT Price Performance

SMA traded up $0.64 during midday trading on Thursday, reaching $34.49. 907,678 shares of the company’s stock were exchanged, compared to its average volume of 801,574. Smartstop Self Storage REIT has a 1-year low of $29.41 and a 1-year high of $39.77. The stock has a market capitalization of $1.91 billion, a PE ratio of 229.91 and a beta of 0.50. The company has a debt-to-equity ratio of 0.86, a current ratio of 5.33 and a quick ratio of 5.33. The business’s 50-day moving average price is $32.99 and its 200 day moving average price is $32.29.

Smartstop Self Storage REIT (NYSE:SMA) last released its quarterly earnings results on Wednesday, May 6th. The healthcare company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.48 by $0.01. Smartstop Self Storage REIT had a net margin of 4.38% and a return on equity of 1.00%. The business had revenue of $78.31 million for the quarter, compared to analyst estimates of $72.56 million. The firm’s quarterly revenue was up 19.7% compared to the same quarter last year. As a group, equities analysts anticipate that Smartstop Self Storage REIT will post 2 EPS for the current fiscal year.

Smartstop Self Storage REIT Increases Dividend

The business also recently announced a monthly dividend, which will be paid on Tuesday, September 15th. Investors of record on Monday, August 31st will be paid a $0.1359 dividend. This represents a c) dividend on an annualized basis and a yield of 4.7%. The ex-dividend date of this dividend is Monday, August 31st. This is an increase from Smartstop Self Storage REIT’s previous monthly dividend of $0.14. Smartstop Self Storage REIT’s dividend payout ratio is currently 1,086.67%.

Analysts Set New Price Targets

Several equities analysts have weighed in on SMA shares. Raymond James Financial initiated coverage on Smartstop Self Storage REIT in a research report on Wednesday, July 15th. They set a “strong-buy” rating and a $39.00 price target for the company. Weiss Ratings upgraded Smartstop Self Storage REIT from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 16th. Wells Fargo & Company reaffirmed a “neutral” rating on shares of Smartstop Self Storage REIT in a research note on Friday, July 24th. Finally, Zacks Research upgraded Smartstop Self Storage REIT from a “strong sell” rating to a “hold” rating in a research report on Friday, May 8th. Two research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Smartstop Self Storage REIT has an average rating of “Moderate Buy” and an average price target of $36.44.

Institutional Trading of Smartstop Self Storage REIT

Several institutional investors have recently made changes to their positions in the stock. JPMorgan Chase & Co. acquired a new stake in shares of Smartstop Self Storage REIT during the 2nd quarter worth $3,155,000. New York State Common Retirement Fund acquired a new position in Smartstop Self Storage REIT in the second quarter valued at $326,000. Quantbot Technologies LP acquired a new position in Smartstop Self Storage REIT in the second quarter valued at $377,000. Invesco Ltd. purchased a new stake in Smartstop Self Storage REIT during the second quarter valued at about $602,000. Finally, Marshall Wace LLP acquired a new stake in Smartstop Self Storage REIT during the second quarter worth about $830,000.

About Smartstop Self Storage REIT

Symmetry Medical Inc (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry.